ANTX · Categories · Form 3
ANTX - SEC Form 3 initial insider statements
AN2 Therapeutics Inc. (ANTX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for ANTX
- New insider Williams Sarah Joanne claimed ownership of 18,800 shares (SEC Form 3)3 - AN2 Therapeutics, Inc. (0001880438) (Issuer)
- New insider Prior Stephen David claimed ownership of 25,217 shares (SEC Form 3)3 - AN2 Therapeutics, Inc. (0001880438) (Issuer)
- New insider Leonard Braden Michael claimed ownership of 4,249,432 shares (SEC Form 3)3 - AN2 Therapeutics, Inc. (0001880438) (Issuer)
- SEC Form 3 filed by new insider Eizen Joshua M3 - AN2 Therapeutics, Inc. (0001880438) (Issuer)
- SEC Form 3 filed by new insider Adjuvant Global Health Technology Fund, L.P. (Amendment)3/A - AN2 Therapeutics, Inc. (0001880438) (Issuer)
- SEC Form 3 filed by new insider Fitzpatrick Margaret M3 - AN2 Therapeutics, Inc. (0001880438) (Issuer)